Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The category Other Pseudomonas aeruginosa surface receptors encompasses a diverse array of proteins and molecular structures located on the outer membrane of the Gram-negative bacterium Pseudomonas aeruginosa (UniProt, 2024). This group includes critical virulence factors such as the Type III secretion system (T3SS) tip protein PcrV, which facilitates the delivery of toxins into host cells, and outer membrane porins like OprF that mediate adhesion and structural stability (PubMed: 25391483). These surface components are vital for the pathogen's ability to colonize host tissues, evade immune responses, and survive in hostile environments like the cystic fibrosis lung (NIH: PMC3133110). As they are exposed to the extracellular space, these receptors are primary targets for the development of monoclonal antibodies and vaccines aimed at neutralizing bacterial toxicity or enhancing immune clearance (PubMed: 19752311). However, the high degree of genetic diversity among P. aeruginosa strains and the protective nature of biofilms present significant hurdles to the broad clinical success of therapies targeting these surface receptors.
Neutralization of the Type III secretion system, inhibition of bacterial attachment to host epithelia, and promotion of antibody-dependent opsonophagocytosis (PubMed: 25391483, NIH: PMC3133110).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other Pseudomonas aeruginosa surface receptors.